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ABSTRACT: The obtaining of the monoclonal antibodies (MAb) in ascitic fluid (hybridoma technique) in Cuba is 
targeted to guarantee the production of recombinant anti-Hepatitis B vaccine. Given its necessary production free 
of contaminating microorganisms, its objective was to evaluate the effectiveness of the Microbiological Control 
Program implemented in production of ascitic fluid rich in MAb in Cuba.  For the program evaluation, microbiological 
(Chi-square, p<0.05), productive and quality indicators in the ascitic fluid production between Stage I (design and 
implementation) and Stage II (evaluation) were analyzed. A lower incidence of microorganisms isolated from 
ozonized drinking water (1-28%) and bedding material (3-12%) in Stage II was evidenced, compared to Stage I (8-
41% from water and 8-38% on bedding material). Likewise, higher values  in the productive indicators [MAb (mg/ml) 
3.41 (Stage I)/6.73 (Stage II) and crude volume/engrafted animal (ml/animal) with 5.26 (Stage I)/7.05 (Stage II)] were 
obtained. Similarly, less quantity of Non-conformities and more Customer Satisfaction were obtained in the quality 
indicators analyzed (Stage II). The Microbiological Control Program implemented in the large-scale production of 
ascitic fluid rich in MAb in Cuba is effective, ensuring the consistency in the specified characteristics of the final 
product for its regulatory approval.
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RESUMEN: En Cuba, la obtención de anticuerpos monoclonales (AcM) en líquido ascítico (técnica de hibridomas) 
está dirigida a garantizar la producción de la vacuna anti-Hepatitis B recombinante. Debido a su necesaria producción 
libre de microorganismos contaminantes, se propuso como objetivo evaluar la efectividad del Programa de Control 
Microbiológico implementado en la producción de líquido ascítico rico en AcM. Para la evaluación del programa se 
analizaron indicadores microbiológicos, productivos y de calidad en la producción de líquido ascítico entre la Etapa I 
(diseño e implementación) y la Etapa II (evaluación). Se evidenció menor incidencia de los microorganismos aislados 
en agua potable ozonizada (1-28%) y material de cama (3-12%) en la Etapa II, comparado con la Etapa I (8-41% en 
agua y 8-38% en material de cama). Asimismo, se obtuvieron valores superiores en los indicadores productivos [AcM 
(mg/ml) 3,41 (Etapa I) / 6,73 (Etapa II) y Volumen crudo/animal prendido (ml/animal) con 5,26 (Etapa I) / 7,05 (Etapa 
II)]. Igualmente, disminuyeron las No Conformidades y se incrementó la Satisfacción del Cliente en los indicadores 
de calidad analizados (Etapa II). El Programa de Control Microbiológico implementado en el proceso productivo de 
líquido ascítico rico en AcM en Cuba es efectivo y permite asegurar la consistencia en las características especificadas 
del producto final para su aprobación regulatoria.
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INTRODUCTION
The hybridoma technique, used for obtaining 
monoclonal antibodies (MAb) with a predetermined 
specificity in ascitic fluid, was introduced in 
1975 for the first time by Köhler and Milstein. 
The widespread use of these compounds in research, 
diagnosis and disease therapy has created the need 
for appropriate methods for their production and 
purification (1). In Cuba, the large-scale production of 
ascitic fluid is developed by the in vivo method at the 
National Centre for the Breeding of Laboratory Animals 
(CENPALAB), with the objective of providing the MAb 
required for the production of the anti-recombinant 
hepatitis B vaccine.
Regulatory institutional bodies such as the World 
Health Organization (WHO), the Federation of Food 
and Drug (FDA) and others establish that this type of 
product should be free of infectious agents, inherent 
wastes to the process of obtaining the hybridoma and 
other impurities proper of the production process (2,3). 
Therefore, the establishment of an efficient quality 
management system with the inclusion of the principles 
of Good Manufacturing Practices (GMP) constitutes 
an aspect of high relevance in this type of production 
process, given that the obtaining of biologics is 
characterized by a great variability for being derived 
from living organisms (4).
Any change in the manufacturing process leads to 
changes in the product that may have some impact 
on its quality, safety and efficacy (4). On the other 
hand, the possible existence of a cross-contamination 
phenomenon will threaten with the quality of the final 
product; hence, it is necessary to employ validated 
processes, standard operating procedures and control 
of process stages, from the identification of critical 
points (5). In this sense, animals are among the 
contamination potential sources of ascitic fluid (variety 
of clinical or subclinical infections) (6), as well as the 
environment quality, the materials used in the ascitic 
fluid obtaining, the equipment, and the personnel (7). 
Keeping this in mind, the adoption of control 
strategies is a priority as part of a Microbiological 
Control Program to prevent, minimize or eradicate 
the dangers of contamination during the production 
process, optimizing the ascitic fluid quality as finished 
product (8). In order to ensure the consistency in the 
specified characteristics of the final product for the 
regulatory approval, it was proposed as objective 
to evaluate the effectiveness of the Microbiological 
Control Program implemented in the large-scale 
production of ascitic fluid rich in MAb in Cuba.
MATERIALS AND METHODS
For the initial design and implementation of the 
Microbiological Control Program, the regulations 
established for the production of biologicals by 
different national and international organizations such 
as WHO (3, 9, 10), Regulation 16 (4), FDA (2), as well 
as the Directive 75/318/EEC (11), EU Guide to Good 
Manufacturing Practice for Medicinal Products for 
Human and Veterinary Use (12), ISO 9000 (5), 10002 
(13) and 19011 (14), and Regulations on Biosafety 
(Decree Law 190  and Biosecurity Manual of the 
National Centre of Biological Security (15, 16)), were 
consulted.
Besides this, a qualitative assessment of 
microbiological contamination risk in the production 
process was developed, a flow chart was designed and 
9 Critical Control Points (animal reception, hybridoma 
reception, animal irritation, hybridoma inoculation, 
extraction, clarification, mixture prefiltration, filtration 
and ascitic fluid expedition) were defined. 
The rules and regulations for monitoring the macro 
and micro environmental factors such as: Standard 
methods for the examination of water and waste water 
of the American Public Health Association (APHA) 
(17),  the Federal Standard 209 E (18) about Clean 
Room and Work Station Requirements, and Controlled 
Environment, were also consulted. 
For the evaluation of the Microbiological Control 
Program implemented in the large-scale production 
of ascitic fluid rich in MAb in Cuba, the analysis of 
microbiological, production and quality indicators were 
taken into consideration as follows:
Evaluation for microbiological indicators 
The microbiological analysis included a period of 13 
years, divided into 2 stages; Stage I from 2000-2005 
(design and implementation) and Stage II from 2006-
2012 (assessment) of the Microbiological Control 
Program established. The Microbiological Control 
Program was designed with a planned monitoring 
system (type and sample quality, sampling frequency 
and method type) for evaluating the air and surface 
quality, and the efficacy of disinfectants (effectiveness 
of the cleaning and disinfection of facilities). Likewise, 
the ozonized drinking water, feed, bedding material, 
operator´s clothing and sterilizable materials, as 
well as the personnel monitoring, the efficacy of the 
sterilization equipments, the non-finished product, 
and final product, were analyzed. In order to verify 
the real effectiveness of the program implemented, an 
assessment of its microbiological indicators was carried 
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out. This program was supported by others such as 
the Cleaning and Disinfection Program, Training and 
Requalification Program for the Staff, Equipment and 
Facility Maintenance Program, and Biosafety Program. 
The results of the microbiological monitoring 
and quality controls to the following elements were 
analyzed:
• Macroenvironmental factors (facilities, barrier 
systems and auxiliaries): The environmental quality 
(air) was monitored by the passive method of the air 
particle sedimentation by gravity (plates exposed) 
weekly, and the opened plates (Plate Count Agar) 
were exposed during 1 h in different places (immobile 
stations).  Once the time is up, the plates at 30-35°C 
for 48 h (bacteria) and later at 22-25°C for 72 h (fungi) 
were incubated. In some cases, the Tryptone Soy 
Agar was used when necessary, where samples at 
35-37°C for 24 h were incubated. The colony forming 
units (CFU) per plate were counted and identification 
was carried out by Gram. The action limits (≥1 CFU/
m3) in the critical areas (critical points) and the alert (≥1 
CFU/m3) and action limits (≥3 CFU/m3) in the support 
critical areas were established. This procedure was 
implemented before the start up and every time these 
facilities were used (17, 19, 20). 
To control surfaces, the swab method was used 
weekly, monthly and before using the barrier and 
auxiliary systems. Matrixes of aluminum paper with 100 
cm2 of area (with an internal cut area of 25 cm2) were 
put on the monitoring surfaces. Later, samples with 
the swab imbibed in saline solution were collected and 
transferred to a tube with saline solution. Afterwards, 
2 ml of the homogenized sample were deposited in 2 
plates (1 ml per plate) with 15 ml of the molten medium 
(Plate Count Agar or Tryptone Soy Agar) and later 
mixing was hardened. Plates at the same conditions 
of temperature and time (bacteria and fungi) as the 
plates exposed method were incubated. Likewise, the 
CFU counting and identification were realized. Finally, 
the CFU number was multiplied per 10 to result in the 
real quantity in 25 cm2. The acceptation limits in the 
Biological Safety Cabinet type II (1 CFU/25 cm2), wall, 
roof, transfer, isolators (5 CFU/25 cm2), and floor (10 
CFU/25 cm2) were established. These controls (both 
methods) were applied to protected areas, clean 
rooms, Biological Safety Cabinet type II, transfer, 
processing equipment, isolators, filters and filtration 
macroisolators of ascitic fluid (17, 19, 20). The factors 
were controlled under automation conditions and 
supervised by the trained personnel. 
• Microenvironmental factors (ozonized drinking 
water, feed, bedding material, operator´s clothing and 
sterilizable material): The microbiological controls 
(mixed testing method) of the bedding material, feed 
and operator´s clothing were applied monthly and 
weekly and each time they (ozonized drinking water) 
were used. Drinking water (10 ml), feed, bedding 
material and operator´s clothing (small pack involved 
in three paper films) were sampled. These samples 
in Thioglycollate Broth and Tryptone Soy Broth were 
inoculated and later incubated at 30-35°C (Thioglycollate 
Broth) and 20-25°C (Tryptone Soy Broth) for 14 days. 
Turbid tube samples to Blood Agar and Mac Conkey 
Agar were transferred and later incubated at 37°C for 
24-48 h. Likewise, the CFU counting and identification 
were carried out (17, 20, 21).  
The sterility control (direct transference method) to 
the sterilizable material (before its use) was used. For 
determining the bacteria and fungi presence, samples 
in Fluid Thioglycollate Medium and Tryptone Soy Broth 
directly and after floming covers were inoculated; later 
they were incubated at 30-35°C (Fluid Thioglycollate 
Medium) and 20-25°C (Tryptone Soy Broth) for 14 
days. Turbid tube samples were considered positive. 
For mycoplasma determining, a direct transference to 
Mycoplasma Broth was performed; and later incubated 
at 35-37°C for 7-14 days. Reactive tube samples 
to Mycoplasma Agar (supplemented) plates were 
transferred and later incubated at 37°C for 7 days with 
10% of CO2. After 7 days, the reversed plates in Optic 
Microscopy (10X) were observed, and the presence of 
typical Mycoplasma colonies were considered positive 
(17, 20, 22). 
• Autoclaves: The sterilization process efficacy 
was assessed weekly by the microbiological control 
method with the use of bioindicator bulbs (Bacillus 
stearothermophilus suspension) by QUIMEFA 
EPB “Carlos J. Finlay” under different times and 
temperatures. Between 3 or 6 bioindicator bulbs were 
introduced into the autoclaves during the sterilization 
process. Later, they were incubated at 55°C for 24-48 
hours. Once the time is up, the yellow color presence 
(pH change) in bulbs indicated that the sterilization 
process was not effective (violet as original color) (20, 
23). 
• Personnel (operator): The pharyngeal exudates, 
feces analysis, clean hands (impression method), 
gloved hands and forearms (swab method) were 
analyzed. The assessment frequency was quarterly 
for pharyngeal exudates and feces analysis, while the 
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other controls were conducted biannually. Pharyngeal 
exudate samples to Blood Agar and Mac Conkey Agar 
were transferred and later incubated at 37 °C for 24-48 h. 
Feces samples to Peptonized Water Regulator 
Solution (37°C for 18-24 h) and Nutrient Broth (37°C for 
24-72 h) were transferred and later incubated. Turbid 
tube samples to 2 tubes of Selenite Cystine Broth 
(one at 42°C for 18-24 h and other at 37°C for 24-48 
h) were transferred and later incubated. Afterwards, 
the turbid tube samples to different agar medium plates 
(Brilliant Green Agar Modified, Salmonella-Shigella Agar 
Modified, Selenite Cystine Agar, Mac Conkey Agar and 
Endo Agar) were extended and later incubated at 37°C 
for 24 h. Likewise, the CFU counting and identification 
were carried out by different methods (Gram, Oxidase, 
Coagulase, Catalase and Api tests) (20, 24).
In the operator control, the clean hands (impression 
method) was performed following the same procedure 
of the plate exposed method from the initial impression 
in the Plate Count Agar to the CFU counting and 
final identification. However, for sampling the gloved 
hands and forearms (swab method), the procedure 
of the control surfaces, was followed but starting 
from the sample collection in saline solution, later its 
transference to the Plate Count Agar and finalizing with 
the CFU counting and the final identification (20, 25).
• Disinfectants: The evaluation of disinfectant 
solutions used in the production process was 
conducted to verify their effectiveness. The evaluation 
frequency was biannually by the antimicrobial action 
method. For this method, it was necessary to use the 
sample (Disinfectant solution) and control (Phosphate 
Buffering Solution) preparation (20, 26).
The disinfectant sample (9.9 ml) was added to 2 
sterile tubes (duplicate), later they were agitated, and 
100 µl of microorganism suspension of reference 
were added in concentration of 10×109 CFU/ml. 
The microorganism suspension was constituted by 
Staphylococcus aureus (ATCC 25923), Escherichia 
coli (ATCC 25922), Pseudomonas aeruginosa 
(ATCC 27853), Candida albicans (ATCC 10231), and 
Aspergillus niger (ATCC 9642). Afterwards, the mixture 
was agitated during 30 seconds, and immediately 1 ml 
of culture was added in 9 ml of Neutralizing Solution. 
Later, 1 ml of culture was added in 9 ml of Phosphate 
Buffering Solution, homogenized again and diluted until 
a dilution of 104. Finally, 1 ml of this mixture was spilled 
in a sterile petri plate, and later 15 ml of fluid Nutrient 
Agar were added, mixed, cooled, and incubated at 
35-37°C for 48 h. Once the time is up,  the CFU/ml 
were counted. The control preparation followed the 
same procedure of the disinfectant sample, but only 
diluting the microorganism suspension of reference in 
Phosphate Buffering Solution until a dilution of 105 (20, 
26).  
The reduction percent (efficacy) of the disinfectant 
samples was calculated as follows (26): 
% of reduction = 100 - ((CFU/ml of sample × 100) / 
CFU/ml of control)).
A value of 75-125×106 CFU/ml in the control 
preparation was evaluated as valid, as well as the 
disinfectant sample with 99.999% of CFU reduction in 
the first 30 seconds was considered as effective (20, 
26). 
These controls were performed in the Quality 
Division according to the procedures established 
in the Manual of Quality Control for the culture and 
identification of contaminating microorganisms in the 
production process of ascitic fluid at CENPALAB. 
Besides these components, the final product was 
included.
Statistical analysis
The frequency analysis was carried out by using 
the independence Chi-square test to compare the 
incidence of biological agents isolated in ozonized 
drinking water and the bedding material (crumbled 
bagasse) during the stages of the study, in which one 
association to p<0.05 was considered as statistically 
significant. The InfoStat v2.0 statistical software was 
used.
The odds ratio (OR) was calculated to determine the 
risk magnitude of the absence of preventive measures 
for the presence of contaminating microorganisms 
in ozonized drinking water and the bedding material, 
where a value of OR≥1 indicated the presence of a risk 
factor; however, an OR<1 indicated to be a protective 
factor (27).
Evaluation for productive indicators
The control charts for some productive indicators 
were established according to ISO 7870 (28), as a 
statistical tool that ensures a continuous monitoring 
of the process and a compliance with product 
specifications, allowing its continuous improvement. 
Warning limits with ± 2 Standard Deviations (SD) 
and action with ± 3SD were established. For this, the 
Minitab v. 16 program was used.  
The productive indicator behavior according to the 
Standard Operation Procedure Manual of the ascitic 
fluid production was analyzed (29), based on the 
Annual Review of Product as it enabled the analysis of 
trends in the process data. To determine performance, 
the following indicators were calculated: performance 
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by engrafted animal (ml/animal) and batch performance 
of the final product (mg/ml).
 The formulas for calculating these indicators are 
(30): 
• Performance by engrafted animal (ml/animal) = 
crude volume/engrafted animals 
• Performance batch of the final product (mg/ml) = 
concentration of MAb/ml  
ml: milliliter, mg: milligrams. 
Evaluation for quality indicators
The behavior of some quality indicators related to 
the Microbiological Control Program implemented in 
the ascitic fluid production was analyzed. Among them 
are:
• Non-conformities identified in internal and 
external audits: In order to evaluate the quality of this 
bioproduct, 8 internal inspections, 10 internal audits by 
ISO 19011(14) and 8 external audits were performed, 
analyzing the non-conformities identified during the 
evaluation process of the ascitic fluid production.
• Claims: Customer´s claims were valued according 
to ISO 10002 (13). A research and a cause analysis for 
taking corrective actions were performed.
 • Customer satisfaction: Customer perception about 
the quality of this product (Customer satisfaction) was 
determined by the method of Perceived Quality Index. 
Survey results sent to the client for 5 years in Stage 
II were taken into consideration; as far back as 2008 
this analysis was inserted for its importance in the 
production process. The interpretation criterion of this 
indicator was: PQI≥1: Satisfied/PQI<1: Not satisfied. 
The following formula was used for calculation (31):
PQI = (5E + 1G + (-1) F + (-5) B) / Total 
E: Excellent, G: Good, F: Fair, B: Bad.
Economic evaluation 
In order to value the economic impact of this 
productive process for the institution and country, 
the total income (resulted of the perceived volume to 
concept of sales of the final product in the evaluated 
period), income per man (obtained from relation 
between the total incomes and total of workers included 
in process), as well as the income per day, and the 
percent of income in the institution were determined 
as efficiency indicators. This monetary value was 
expressed in Cuban pesos (CUP).
RESULTS AND DISCUSSION
The results analysis of the microbiological, 
productive and quality indicators will be shown as 
follows.
Evaluation for microbiological indicators
Among the microenvironmental elements monitored 
in both stages (water, bedding material, food, clothing 
and other sterilizable materials), only the non-compliant 
results in water and the bedding material were obtained 
(21). The rest of the macroenvironmental factors 
controlled (facilities, barrier and auxiliary systems) 
behaved in correspondence with the acceptance limits 
defined (19).
The incidence of microorganisms isolated from 
ozonized drinking water during Stages I and II is shown 
in Table 1. 
Among the agents identified, Bacillus sp. 
(environment microbiota) and Staphylococcus sp. 
TABLE 1. Incidence by stages of microorganisms isolated from ozonized drinking water./ Incidencia por etapas de 
los microorganismos aislados en agua potable ozonizada.





I 130 106 24 0.82 0.18
5.31 0.0212 2.05II 231 208 23 0.90 0.10
Enterococcus sp. I 130 120 10 0.92 0.08 14.84 0.0001 19.17II 231 230 1 0.99 0.01
Escherichia coli I 130 119 11 0.92 0.08 2.59 0.1073 -
II 231 221 10 0.96 0.04
Bacillus sp. I 130 77 53 0.59 0.41 6.03 0.0141 1.76II 231 166 65 0.72 0.28
S: Samples, (-): Negative, (+): Positive, OR: Odds ratio.
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(skin microbiota) were considered environmental 
contaminants, while Enterococcus sp. and Escherichia 
coli were classified as opportunistic pathogens (skin 
or mucosal microbiota) (9, 32, 33). These findings 
coincided with others obtained in previous studies 
by Riera (34), who also obtained isolates of these 
bacterial entities from ozonized drinking water, being 
Bacillus sp. and Staphylococcus sp. the ones with the 
highest incidence (37.5 and 15.6%, respectively). 
Likewise, Caorsi et al. (32) evidenced that 
Staphylococcus sp. was the most frequently 
environmental contaminant in the sterile preparation 
units from the Chilean Clinical Hospital studied, followed 
by Micrococcus sp. and Bacillus sp. In this sense, 
Donatién (35) demonstrated an incidence of 48% of 
Staphylococcus sp. as environmental contaminant 
in Cuba, while Hernández and Marín (36) reported 
the presence of this microbial entity in environmental 
controls in human meeting places (library) in Colombia.
The opportunistic pathogens were naturally present 
in the environment. Not  considering them as defined 
pathogens may eventually cause human diseases 
whose mechanisms of local or systemic defenses were 
deficient. If drinking or bath water contains a significant 
number of microorganisms, it can be a source of skin 
and mucosal infection. This can be confirmed in reports 
or studies carried out by WHO (9) and Llop et al. (37), 
where they referred to Pseudomonas aeruginosa, 
Escherichia coli and to a lesser degree species of 
Flavobacterium, Acinetobacter, Klebsiella, Serratia 
and Aeromonas, as well as some slow-growing 
mycobacteria, as major opportunistic pathogens in 
water. 
Taken into consideration that the treatment of 
drinking water with ozone is considered an effective 
mechanism for sterilizing bacteria and viruses 
according to the statements made by Bataller et 
al. (38), the presence of the isolated bacteria could 
be the result of contamination of the passageways 
colonized within the water distribution network. This 
coincided with Allen (39), who noted that Enterobacter, 
Staphylococcus, Pseudomonas and Klebsiella species 
frequently colonized the inner surfaces of water pipes 
and storage tanks (often called “flare”) and grew into 
biofilms when conditions were favorable, such as 
the presence of nutrients, warm temperatures, low 
concentrations of disinfectants and long storage, 
among others.
The isolated agents may have been transmitted to 
the water as a result of the condition of the ducts and 
pipes of the treatment system and their distribution 
according to what was stated by WHO (10), possibly 
having a negative influence on the quality and 
production process stability. Likewise, Goya and Wilde 
(40) reported that the construction defect or structures 
of deposits, as well as the absence or irregularities in 
the maintenance of facilities, constituted causes for the 
presence and growth of microorganisms from different 
sources.
These isolates in ozonized drinking water used 
in the productive process entailed the establishment 
of a maintenance plan as part of the Technology 
Management System implemented in Gnotobiotic 
Rodent Management. It consisted on circulating water 
with high concentrations of ozone in the pipes for 1 
hour; besides including the checking and cleaning 
of deposits and ozone generating equipment with 
monthly frequency.
The incidence of isolated contaminant 
microorganisms in ozonized drinking water is shown 
in Table 1. Bacillus sp. had the major incidence in both 
stages due to its high resistance in environment, as 
dust and soil microbiota, followed by Staphylococcus 
sp. as another common environment contaminant 
but from the human and animal skin microbiota 
(32). However, the results achieved in Stage II 
showed an improvement in the quality of ozonized 
drinking water in relation to the previous stage, since 
Enterococcus sp. was scarcely reported and nor the 
incidence of the rest of the isolated agents or other 
contaminants. These findings demonstrated that 
the implementation of the Microbiological Control 
Program improved the microbiological quality of this 
contaminant source through a considerable reduction. 
Analyzing the statistical processing (Chi-square) 
of the results obtained in both stages, statistically 
significant differences (p<0.05) were observed in the 
percentage values  of Staphylococcus sp., Bacillus sp. 
and Enterococcus sp. incidence in ozonized drinking 
water with a significant decrease in Stage II. Unlike 
the percentage values  of Escherichia coli showed no 
significant differences although its incidence was lower 
(Table 1). 
Water contamination and changes in its chemical 
composition can affect the health of animals and the 
results of the final product quality, since it is used in all 
the activities of the productive process, cleaning and 
preparation of solutions, as well as in the staff bath to 
enter the protected area, and in the maintenance of 
rodents as they constitute important factors to control 
(29).
The statistical analysis confirmed the effectiveness 
of the measures taken to achieve improvements in 
the quality of the water used in the process, since a 
significant reduction of microorganisms was identified. 
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Likewise, it was necessary to implement other actions 
to eradicate the bacterial agents isolated in the water 
which could potentially affect the quality of the finished 
product.
The odds ratio values  obtained in both stages (Table 
1) showed (in Stage II) a decrease in the risk magnitude 
of water contamination by such agents, since lower 
values  of this indicator were obtained compared 
with Stage I. This defined the absence of preventive 
measures as a risk factor for the contamination of 
Enterococcus sp., Staphylococcus sp. and Bacillus sp. 
in 19.17; 2.05 and 1.76 times higher for this type of 
sample respectively; compared with the presence of 
the measures to prevent water contamination by these 
microbial entities (27). 
The incidence of isolated agents in crumbled 
bagasse (alternative source of bedding material) 
during the stages studied is shown in Table 2. It can 
be seen that in Stage I Bacillus sp. and Escherichia 
coli were the most isolated microbial entities; followed 
by Proteus sp. and in a lower percentage of isolation 
Pseudomonas aeruginosa. The presence of these 
agents in the bedding material could have been 
obtained from the origin source or storage conditions, 
which can favor contamination when they are not 
adequately controlled. According to the statements 
made by Francis et al. (41), cellulose and sucrose 
content in its composition, and its residual moisture 
(about 8%) favored the multiplication of these 
microorganisms when the sterilizing process was not 
effective.
In the analysis of the results with the statistical 
processing (Chi-square) of the sterility control in 
the  bedding material in the two stages of the study, 
significant statistical differences (p<0.05) were 
observed in Stage II, with a marked decrease in the 
incidence of bacteria that had been identified in Stage 
I (Table 2). However, Pseudomonas aeruginosa had 
a lower incidence in the second stage, although a 
statistically significant difference was not evidenced as 
compared to Stage I.
These isolations coincided with the approach 
made by Riera (34) in studies carried out about the 
microbiological behavior in dehydrated crumbled 
bagasse as bedding material for rodents free of specific 
pathogens, and subsequent works related to the 
health monitoring and maintenance of microbiological 
hygienic condition in experimental rodents.
The presence of these bacteria entities in the 
bedding material showed the need to make adjustments 
to the sterilization process which was made from the 
microbiological results obtained in Stage I (Table 2), 
on adjustments in sterilizing time for this material. 
The drying stage and a maximum storage time for a 
week was made longer, which allowed to obtain better 
results in Stage II; therefore a significant decrease was 
observed as mentioned above. 
Analyzing the odds ratio values  obtained (Table 2), 
it was found that the corrective measures implemented 
enabled to reduce the magnitude of the contamination 
risk by these entities in Stage II, since the absence of 
preventive measures increased the contamination risk 
by Proteus sp., Bacillus sp. and Escherichia coli in 8.29; 
5.17 and 3.06 times respectively; compared with the 
presence of measures to prevent the contamination of 
the bedding material for these microbial entities (27). 
Based on these arguments, this indicator confirmed 
the effectiveness of the measures applied, directing 
TABLE 2. Incidence by stages of microorganisms isolated from the bedding material./ Incidencia por etapas de los 
microorganismos aislados en material de cama.





I 86 53 33 0.62 0.38
22.20 <0.0001 5.17II 121 108 13 0.89 0.11
Proteus sp. I 86 67 19 0.78 0.22 17.97 <0.0001 8.29II 121 117 4 0.97 0.03
Escherichia coli I 86 60 26 0.70 0.30 10.07 0.0015 3.06II 121 106 15 0.88 0.12
Pseudomonas aeruginosa I 86 79 7 0.92 0.08 1.48 0.2241 -
II 121 116 5 0.96 0.04
S: Samples, (-): Negative, (+): Positive, OR: Odds ratio. 
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the use of corrective actions to other alternatives that 
allowed obtaining a completely free of contaminant 
bedding material. 
In the bedding material, Bacillus sp. had the major 
incidence in Stage I, again due to its high resistance 
in environment such as dust and soil microbiota 
(32), as it was previously mentioned. However, once 
more it is demonstrated that the implementation of 
the Microbiological Control Program improved the 
microbiological quality of this another contaminant 
source through a significant reduction. 
Another control carried out as a part of the 
Microbiological Control Program was the health 
monitoring of the staff. In this case, the highest 
prevalence of microorganisms identified was in the 
pharyngeal exudates (Fig. 1), being the results of 
the stool analysis and vaginal exudates insignificant 
in the laboratory analysis (24). The positive staff was 
separated from the productive activity and subjected to 
treatments with subsequent rechecking. 
FIGURE 1. Prevalence by stages of microorganisms isolated in pharyngeal exudates from the staff./Prevalencia por etapas 
de los microorganismos aislados en exudados faríngeos del personal.
During the two stages, high Staphylococcus aureus 
prevalence values were evidenced and identified 
through all the years studied (Fig. 1). This result 
coincided with the findings made by Riera (34), who 
reported this bacterium as the most prevalent in the 
staff pharyngeal exudates, reaching percentages of 
isolation up to 50%. This microorganism is referred to 
in the literature as normal microbiota of the pharynx, 
although it is also considered an opportunistic pathogen 
that could eventually cause inflammatory processes, 
not only in humans, but also in animals. Therefore it 
is controlled and measures are taken (9, 42), deriving 
to the positive cases of Staphylococcus aureus β 
hemolytic which could be considered by a physician to 
value the needs of a specific antibiotic treatment. 
Pseudomonas aeruginosa and Escherichia coli had 
the major annual persistence after Staphylococcus 
aureus in the pharyngeal exudate samples (Fig. 1). The 
results obtained showed that these microorganisms 
have been considered as major opportunistic 
pathogens in the environment, particularly in drinking 
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FIGURE 2. Performance evaluation in crude volume/animal engrafted and MAb of the ascitic fluid./ Evaluación del rendi-
miento en Volumen crudo/animal prendido y AcM del líquido ascítico.
water (9, 37). In this sense, the strict application of 
corrective measures in the drinking water treatment is 
one of the most important actions to reduce the future 
contaminations of facilities and personnel (17).  
In another sense, the analysis of the operator 
control was acceptable in the majority of the samplings 
(25). The sterilization process efficacy (autoclaves) 
(23), sterility control of the sterilizable materials (22) 
and the evaluation of disinfectant solutions (26) were 
considered satisfactory. These findings demonstrated 
that the measures taken after the implementation of 
the Microbiological Control Program improved the 
microbiological quality of these contaminant sources 
in Stage II.
Regarding the quality of the finished product with the 
implementation of the Microbiological Control Program, 
a product free of contaminating microorganisms was 
obtained, which ensured the quality specifications 
fulfillment, allowing the release of all the batches 
produced. 
Evaluation for productive indicators
 Monitoring the productive performance of each 
operator starting by the analysis of these indicators 
was of great importance since it has been highly 
demonstrated that the way productivity increased 
when ensuring an adequate health maintenance and 
handling of animals (8).
As can be seen in Fig. 2, the performance of the 
ascitic fluid, both in crude volume/animal engrafted 
and MAb, increased considerably in Stage II (2006-
2012) after the implementation of the Microbiological 
Control Program, demonstrating its effectiveness. 
This is made clear by taking into consideration 
the comment of the previous paragraph, plus the fact 
that once the contamination of the final product is 
demonstrated, it should be reprocessed so that part 
of the volume and concentration of MAb produced 
is lost. That is why the strict application of controls 
and preventive measures ensured their entire 
microbiological quality of the process. 
The lowest performances described as alert 
(-2SL) and action limits (-3SL) may be indicatives 
of the presence of a subclinical infection affecting 
the productive potential of these animals. This is 
quite common in laboratory rodents according to 
the statements made by Shek (6), who referred that 
there was a wide variety of microorganisms affecting 
experimental rodents, where most of the infections 
had no clinical symptomatology. Therefore, there was 
a risk of not being detected to interfere in the research 
results and processes in which these biomodels were 
used.
 In contrast with these mentioned criteria, the superior 
performances defined as alert (+2SL) and action 
limits (+3SL) indicated a surplus of these productive 
indicators for the efficacy of the Microbiological Control 
Program implemented, as the tendency to increase in 
Stage II (2006-2012), shown in Fig. 2. Thus, in fulfilling 
the objectives, plans and predicted goals, delivery 
of MAb in the quantity and quality required for its 
regulatory approval were ensured. 
Evaluation for quality indicators
The non-conformities results detected in 
inspections, internal and external audits, as well as 
claims and evaluations of customers´ satisfaction, 
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and the quality indicators promoting the continuous 
improvement of processes will be shown as follows.
Non-conformities detected in internal and external 
audits
In this productive process, the Quality Management 
established annually the Internal Audit Program, whose 
objective was to assess the compliance of the Good 
Production Practice (GPP) and verify the aspects of 
the Quality Management System. For these audits, 
there was a competent group of independent experts 
who were not related to the process that constituted 
the audit team.
The non-conformities detected during inspections 
and internal audits conducted by the Quality 
Management to the ascitic fluid production rich 
in MAb from 2000 to 2012 are shown in Fig. 3, 
showing a decreasing tendency, which evidence the 
improvements in the process, as well as the proper 
performance of the GPP.
The detection of non-conformities allowed to design 
an Improvement Program made up of corrective 
measures directed to optimize the documentary 
system, the constructive condition of the facilities, the 
calibration and verification of the equipment, and the 
purchase of the necessary equipment for the control of 
harmful elements like ammonia and ozone.
This allowed advancing in the productive process 
integrity since many of these non-conformities could 
negatively influence on the effectiveness of the 
Microbiological Control Program, as they directly 
affected the micro and macroenvironmental factors 
already mentioned above. At the same time, this 
allowed the establishment of action priorities to 
eliminate those causes that threatened the product 
quality in each stage of the process.
Other institutions have also conducted numerous 
audits to this productive process, among them are 
those made by the Centre for the Quality State 
Control of Drugs, Equipments and Medical Devices 
FIGURE 3. Behavior of the non-conformities detected during the internal and external audits performed on the ascitic fluid 
production process./Comportamiento de las No Conformidades detectadas en auditorías internas y externas realizadas al 
proceso de producción de líquido ascítico.
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(CECMED) to grant the Production License, as well 
as the Supplier audits conducted by the Center for 
Genetic Engineering and Biotechnology (CIGB), 
and the Center of Molecular Immunology (CIM). 
The major non-conformities detected in these audits 
are referred to aspects in which large investments 
(equipment to control harmful elements, automation, 
etc.) are required. These identified deficiencies have 
been resolved gradually, which are evidenced by the 
significant reduction of the non-conformities through 
the years, mainly in Stage II as shown in Fig. 3.
In general, the importance to eliminate the non-
conformity is in guaranteeing the improvement of the 
ascitic fluid production, as the automated equipment 
optimizes the control on the process, at the same 
time favoring the effectiveness of the Microbiological 
Control Program established, conditioned by the strict 
control over the quality of the environment for animals 
and the treatment of drinking water and food.
The stated aspects do not invalidate the GPP, as the 
Production License was granted by the CECMED in 
1999, and the acceptability by WHO of the production 
of anti-Hepatitis B vaccine in 2001, 2002, 2004, 2006, 
2008, 2010 and 2012, making possible that our country 
commercializes vaccines and other drugs through 
institutions of the United Nations (UN) to other regions 
and countries of the world.
Claims 
This indicator also starts to be evaluated as part 
of the continuous improvement process, agreeing 
with the points made by Sosa (8), who stated that 
the organization should continually improve the 
effectiveness of its system or process with the use 
of some tools such as results of inspections, audits, 
corrective and preventive actions, surveys of customer 
satisfaction and data analysis. The behavior of claims´ 
number is shown in Fig. 4.
During all the years of the study, this indicator 
was below the acceptable value determined by the 
institution (1%), highlighting that during recent years 
the claims have been from 0.15 to 0.10% of the total 
batch issued. The causes of these claims are related 
to transportation (delivery time), lack of communication 
between the parties, but not to the quality specifications 
of the product (8).
Customer satisfaction
Surveys were conducted in order to know the 
perception of the customers about the ascitic fluid 
production rich in MAb issued for the production of 
recombinant anti-Hepatitis B vaccine, since annual 
surveys were conducted in 2008. Their results provided 
the necessary information to take actions to improve 
the process.
The values of the Perceived Quality Index (PQI) 
calculated from the survey results made to the 
customers evidenced a PQI of 1.6 (2008), 2.6 (2009), 
3.3 (2010), 2.2 (2011), and 1.7 (2012) for the centers 
evaluated.
The answers given by the clients were fully 
compliant, allowing to have the perception estimation 
of these customers satisfied (PQI ≥ 1) with the quality 
of MAb obtained at CENPALAB for its use in the 
production of the vaccine. As it can be appreciated, the 
overall satisfaction degree remained as a satisfactory 
performance, even though the regulations and 
requirements for this type of product increase every 
year (13, 31).
Economic evaluation 
Table 3 shows the behavior of some efficiency 
indicators in the productive process, as a result of 
the Microbiological Control Program effectiveness 
implemented with the support of other established 
programs, mentioned above.
The results achieved, in relation to the total volume 
obtained (Table 3), made the country save about $ 21 
million annually, according to the current prices in the 
world market for this type of product. In addition, the 
productivity achieved was outstanding, since the group 
of technicians and specialists involved in the process 
was reduced in a half since 2004, maintaining and 
improving the productive results with a high level of 
expertise and a significant reduction of salary costs.
FIGURE 4. Behavior of the claims in the ascitic fluid pro-
duction./Comportamiento de las Reclamaciones en la pro-
ducción de líquido ascítico.
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On the other hand, it was not necessary either to 
import any animals needed for obtaining this biological 
product, whereof prices in the world would have been 
uneconomical, since large volumes of MAb for the 
production process of the anti-Hepatitis B vaccine are 
required, therefore the need to import a large number 
of animals to produce the volume required. 
In relation to the incomes obtained for marketing this 
biological product, it should be noted that this productive 
process has contributed since its establishment until 
today with 36.24% of the total income of the institution; 
generating an income/peso spent of $3.48; in addition 
to the added value of the medicines generated and 
evaluated from this bioproduct. It contributes to the 
development of biotech drugs produced by other 
institutions (CIGB and CIM), whose exports provide 
substantial contributions to the Cuban economy.
The adoption of control strategies as part of the 
Microbiological Control Program constituted a priority 
to prevent, minimize or eradicate the contamination 
dangers during the production process, optimizing the 
ascitic fluid quality as a finished product. 
Ensuring that this program contributes to the 
safety, efficacy and stability of the final product was 
the major impact in the productive process of ascitic 
fluid, guaranteeing the consistency in its specified 
characteristics for the regulatory approval. In this 
sense, the obtaining of major productive performances 
stimulated the diversification of the MAb production, 
generating superior economical profits for our 
institution. Likewise, in this production diversity, 
major uses in the Cuban Biotechnology Industry were 
obtained, not only in the preventive and therapeutic 
vaccine productions for the infectious diseases, but 
also in the diagnosis, following and the treatment of 
cancer, as well as the T lymphocytes quantification in 
the peripheral blood, among others (29). 
CONCLUSIONS
Based on the results obtained, it is concluded that 
the Microbiological Control Program implemented in 
the productive process of the ascitic fluid rich in MAb 
in Cuba is effective, allowing to ensure consistency in 
the specified characteristics of the final product for the 
regulatory approval. 
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